top of page
Endovascular Innovations: The Ellipsys Story with Dr. Jeffrey Hull, Dr. Aaron Fritts on the BackTable Industry Podcast
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Industry

Episode # 81  •  27 Sept 2024

Endovascular Innovations: The Ellipsys Story

Surgical arteriovenous fistula (AVF) creation has been a mainstay of dialysis care for multiple decades. What does it take to break into such an established space with a new endovascular medical device? In this episode of the BackTable Podcast, Dr. Jeffrey Hull discusses the challenging journey of developing the Ellipsys system for endovascular AVF creation.

Timestamps

00:00 - Introduction
03:05 - The Birth of the Percutaneous AV Fistula Creation
15:04 - First-in-Human Cases
17:58 - Navigating the Startup Journey
21:52 - Identifying Mentors and Investors
27:33 - Competition and Criticism
36:43 - Regulatory Hurdles
44:45 - Acquisition by Medtronic
49:14 - Deep Vein Arterialization for Peripheral Arterial Disease
54:40 - Final Thoughts and Advice

Resources

You may also like

See more of the content that's relevant to your practice.

More about this episode

We trace Dr. Hull’s path from the device's initial conception in 2006, through the first-in-human cases in 2013, to regulatory approval and acquisition by Medtronic in 2020. Dr. Hull highlights the roles of key business mentors, the importance of multidisciplinary collaboration with vascular surgery and nephrology, and the impact of investment. He also shares valuable insights on the benefits of having competitors and selecting a well-thought-out exit strategy. Additionally, we explore deep vein arterialization (DVA) as another application of endovascular AVF creation in the context of peripheral arterial disease.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page